GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aveanna Healthcare Holdings Inc (NAS:AVAH) » Definitions » YoY EBITDA Growth

Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) YoY EBITDA Growth : 106.85% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aveanna Healthcare Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aveanna Healthcare Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 106.85%.

Aveanna Healthcare Holdings's EBITDA per Share for the three months ended in Dec. 2023 was $0.07.


Aveanna Healthcare Holdings YoY EBITDA Growth Historical Data

The historical data trend for Aveanna Healthcare Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveanna Healthcare Holdings YoY EBITDA Growth Chart

Aveanna Healthcare Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial 17.14 38.62 -130.79 -2,595.24 107.28

Aveanna Healthcare Holdings Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -94.70 -79.43 115.51 -190.91 106.85

Aveanna Healthcare Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aveanna Healthcare Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.206--2.83)/ | -2.83 |
=107.28 %

Aveanna Healthcare Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.073--1.065)/ | -1.065 |
=106.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aveanna Healthcare Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Aveanna Healthcare Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) Business Description

Traded in Other Exchanges
N/A
Address
400 Interstate North Parkway SE, Suite 1600, Atlanta, GA, USA, 30339
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. HHH segment provides home health, hospice, and specialty program services to elderly populations seeking compassionate care and assistance with activities of daily living in the home. MS segment provides needed supplies to patients requiring enteral nutrition services or respiratory care.
Executives
Deborah Stewart officer: SVP, Chief Accounting Officer 400 INTERSTATE NORTH PARKWAY SE, ATLANTA GA 30339
Matthew Buckhalter officer: See Remarks 400 INTERSTATE NORTH PARKWAY SE, SUITE 1600, ATLANTA GA 30339
Victor F Ganzi director
David Afshar officer: Chief Financial Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Patrick A. Cunningham officer: Chief Compliance Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Edwin C. Reisz officer: Chief Administrative Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Jeff Shaner officer: Chief Operating Officer 3350 RIVERWOOD PARKWAY SUITE 1400, ATLANTA GA 30339
Tony Strange director, officer: Chief Executive Officer 3 HUNTINGTON QUADRANGLE 2S, MELVILLE NY 11747
Rodney D Windley director, officer: Executive Chairman 3 HUNTINGTON QUADRANGLE 2S, MELVILLE NY 11747
Steven E Rodgers director
Erica Schwartz director 400 INTERSTATE N. PARKWAY SE, SUITE 1600, C/O AVEANNA HEALTHCARE HOLDINGS INC., ATLANTA GA 30339
Bcip Associates Iv-b (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Whitney Strategic Partners Vii, L.p. 10 percent owner 130 MAIN STREET, NEW CANAAN CT 06840
Bcip T Associates Iv-b (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bcip T Associates Iv (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116